Duratia 90 mg, which contains Dapoxetine, is specifically designed to treat premature ejaculation (PE) in men. It works by increasing serotonin levels in the brain to help delay ejaculation and improve control during sexual activity. Here’s why Duratia 90 mg is not used for women:

Mechanism of Action: Dapoxetine's primary mechanism is to inhibit the reuptake of serotonin, a neurotransmitter that affects mood and ejaculation. This mechanism is tailored to address premature ejaculation, a condition specific to men. It does not have a direct therapeutic effect on sexual function or desire in women.

Indication: Duratia 90mg is approved and indicated specifically for the treatment of PE in men. There is no established evidence or approval for its use in women for any sexual health condition.

Research and Approval: The clinical research and regulatory approvals for Dapoxetine have focused on its efficacy and safety in treating PE in men. There is a lack of clinical data and approval for its use in women, so its effects and safety for female patients are not well understood.

Alternative Treatments for Women: Women with sexual dysfunction or related issues are generally treated with different medications and therapies tailored to their specific conditions. For example, treatments for female sexual arousal disorder might include hormonal therapies, lubricants, or other medications specifically designed for women.

In summary, Duratia 90 mg is designed and approved for use in men to manage premature ejaculation and is not intended for or effective in treating sexual issues in women. For women with sexual health concerns, it is best to consult with a healthcare provider to explore appropriate treatments tailored to their needs.